Development of pneumococcal mastoiditis due to multidrug-resistant serotype 19A despite three doses of 13-valent pneumococcal vaccine

被引:5
|
作者
Ruck, Richard C. [1 ]
Eberly, Matthew D. [1 ]
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Pediat Infect Dis, F Edward Hebert Sch Med, Bethesda, MD 20814 USA
关键词
Streptococcus pneumoniae; Mastoiditis; Serotype; 19A; ACUTE OTITIS-MEDIA; CONJUGATE VACCINE; FREQUENCY; EMERGENCE; EFFICACY; DISEASE;
D O I
10.1016/j.ijporl.2012.08.018
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Acute mastoiditis is a potential complication of acute otitis media (AOM), with Streptococcus pneumoniae historically the most common pathogen isolated. Following the release of the 7-valent pneumococcal conjugate vaccine in 2000, a marked decline in invasive pneumococcal disease and a smaller reduction in pneumococcal AOM were observed, but data regarding its impact on acute mastoiditis are limited. With the recent introduction of the 13-valent pneumococcal conjugate vaccine (PCV13), it is anticipated that pneumococcal AOM and invasive disease will further diminish. We report a case of acute mastoiditis from a multidrug-resistant serotype 19A S. pneumoniae in an immunocompetent child who had received three PCV13 vaccinations. Published by Elsevier Ireland Ltd.
引用
收藏
页码:1849 / 1851
页数:3
相关论文
共 50 条
  • [1] Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates
    Ongkasuwan, Julina
    Valdez, Tulio A.
    Hulten, Kristina G.
    Mason, Edward O., Jr.
    Kaplan, Sheldon L.
    PEDIATRICS, 2008, 122 (01) : 34 - 39
  • [2] The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on serotype 19A invasive pneumococcal disease
    Principi, Nicola
    Esposito, Susanna
    EXPERT REVIEW OF VACCINES, 2015, 14 (10) : 1359 - 1366
  • [3] Serotype 3 Antibody Response and Antibody Functionality Compared to Serotype 19A Following 13-Valent Pneumococcal Conjugate Immunization in Children
    Fuji, Naoko
    Pham, Minh
    Kaur, Ravinder
    E. Pichichero, Michael
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2024, 43 (03) : 294 - 300
  • [4] A case report of parapneumonic pleural effusion caused by Streptococcus pneumoniae serotype 19A in a child immunized with 13-valent conjugate pneumococcal vaccine
    Diawara, Idrissa
    Zerouali, Khalid
    Elmdaghri, Naima
    Abid, Abderrahman
    BMC PEDIATRICS, 2017, 17
  • [5] Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona
    Munoz-Almagro, Carmen
    Esteva, Cristina
    Fernandez de Sevilla, Maria
    Selva, Laura
    Gene, Amadeu
    Pallares, Roman
    JOURNAL OF INFECTION, 2009, 59 (02) : 75 - 82
  • [6] 13-Valent vaccine serotype pneumococcal community acquired pneumonia in adults, in high clinical risk groups
    Daniel, Priya
    Rodrigo, Chamira
    Bewick, Thomas
    Sheppard, Carmen
    Greenwood, Sonia
    McKeever, Tricia M.
    Trotter, Caroline
    Lim, Wei Shen
    VACCINE, 2018, 36 (12) : 1614 - 1620
  • [7] Pneumococcal disease caused by serotype 19A: Review of the literature and implications for future vaccine development
    Reinert, Ralf Rene
    Jacobs, Michael R.
    Kaplan, Sheldon L.
    VACCINE, 2010, 28 (26) : 4249 - 4259
  • [8] Pneumococcal Conjugate Vaccine-elicited Antibody Persistence and Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Children Previously Vaccinated with 4 Doses of Either 7-Valent or 13-Valent Pneumococcal Conjugate Vaccine
    Quinet, Beatrice
    Laudat, France
    Gurtman, Alejandra
    Patterson, Scott
    Sidhu, Mohinder
    Gruber, William C.
    Scott, Daniel A.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (10) : 1065 - 1076
  • [9] Impact of the 13-valent pneumococcal conjugate vaccine on Streptococcus pneumoniae multiple serotype carriage
    Valente, Carina
    Hinds, Jason
    Gould, Katherine A.
    Pinto, Francisco R.
    de Lencastre, Herminia
    Sa-Leao, Raquel
    VACCINE, 2016, 34 (34) : 4072 - 4078
  • [10] Non-vaccine serotype pneumococcal carriage in healthy infants in South Africa following introduction of the 13-valent pneumococcal conjugate vaccine
    Skosana, Z.
    von Gottberg, A.
    Olorunju, S.
    Mohale, T.
    du Plessis, M.
    Adams, T.
    Mbelle, N.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2021, 111 (02): : 143 - 148